Lidocaine ultrasonic nebulization inhalation combined with tracheal tube coating inhibits the stress response of double-lumen tube intubation and extubation

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000038659

Enrollment

Unknown

Registered

2020-09-29

Start date

2020-09-27

Completion date

Unknown

Last updated

2020-12-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chest disease

Interventions

blank:NS

group b:Lidocaine ultrasonic nebulization

group c:Lidocaine ultrasonic atomization combined with lidocaine cream application

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients with ASA grade I ~ II, 2. Patients aged 18-65 years, 3. Patients with body mass index (BMI) of 18-25kg / m2

Exclusion criteria

Exclusion criteria: 1. Patients with drug allergy history; 2. Patients with history of cardio pulmonary cerebrovascular diseases; 3. Patients with difficult airway; 4. Patients with chronic pain; 5. Patients with chronic history; 6. Patients who take medicine for a long time; 7. Patients with history of esophageal and gastric diseases; 8. Patients with endocrine diseases.

Design outcomes

Primary

Measure	Time frame
The incidence of sore throat in the sixth hour after surgery;	—

Secondary

Measure	Time frame
Incidence of sore throat at 0, 1, 12 hours after extubation;BP;HR;SPO2;blood sugar;Catecholamine plasma concentration;	—

Contacts

Public ContactMingjian Kong

Xuzhou Mining Group General Hospital

mjkong@126.com+86 17751991669

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026